The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors

Overview of attention for article published in Frontiers in oncology, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,437 followers.

We've detected a paper from Frontiers in Oncology that cites a retracted paper post-retraction. Citing paper: https://t.co/qju1om0fO4 Retracted paper: https://t.co/0I7okMgXu0

06 May 2023

Reply Repost Favourite

RT @FrontOncology: New research: The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors: Virtual Touch Tissue Quantifi…

31 Mar 2023

Reply Repost Favourite

New research: The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors: Virtual Touch Tissue Quantification (VTQ) offers several advantages in the diagnosis of various lung diseases. Chemokine expression levels, such as… https://t.co/mVx

31 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.